Appelhans Dannielle
CIK: 0001874962
Director
Primary company: Rubius Therapeutics, Inc. (RUBY)
Appelhans Dannielle is a corporate insider at Rubius Therapeutics, Inc. (RUBY) filing SEC Form 4 transactions. 18 transactions across 2 companies, totaling $32,339 in purchases and $6,882 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 30,000 | - | - | 30,000 | 6/4/2025 Filed: 6/6/2025 | Filing → | |
| Award | 60,000 | - | - | 60,000 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Purchase | 7,363 | $1.79 | $13K | 7,363 | 12/8/2023 Filed: 12/11/2023 | Filing → | |
| Purchase | 637 | $1.82 | $1K | 12,637 | 12/8/2023 Filed: 12/11/2023 | Filing → | |
| Purchase | 12,000 | $1.50 | $18K | 12,000 | 12/4/2023 Filed: 12/6/2023 | Filing → | |
| Award | 25,000 | $0.00 | $0 | 25,000 | 6/8/2023 Filed: 6/12/2023 | Filing → | |
Rubius Therapeutics, Inc. RUBY | Sale | 10,385 | $0.13 | $1K | 0 | 2/24/2023 Filed: 2/27/2023 | Filing → |
Rubius Therapeutics, Inc. RUBY | Sale | 3,878 | $0.25 | $970 | 10,385 | 2/1/2023 Filed: 2/1/2023 | Filing → |
Rubius Therapeutics, Inc. RUBY | Exercise | 7,500 | $0.00 | $0 | 22,500 | 1/31/2023 Filed: 2/1/2023 | Filing → |
Rubius Therapeutics, Inc. RUBY | Exercise | 7,500 | - | - | 14,263 | 1/31/2023 Filed: 2/1/2023 | Filing → |
Rubius Therapeutics, Inc. RUBY | Sale | 5,737 | $0.80 | $5K | 6,763 | 8/10/2022 Filed: 8/12/2022 | Filing → |
Rubius Therapeutics, Inc. RUBY | Exercise | 12,500 | $0.00 | $0 | 37,500 | 8/9/2022 Filed: 8/12/2022 | Filing → |
Rubius Therapeutics, Inc. RUBY | Exercise | 12,500 | - | - | 12,500 | 8/9/2022 Filed: 8/12/2022 | Filing → |
| Award | 38,400 | $0.00 | $0 | 38,400 | 7/15/2022 Filed: 7/19/2022 | Filing → | |
Rubius Therapeutics, Inc. RUBY | Award | 30,000 | $0.00 | $0 | 30,000 | 1/31/2022 Filed: 2/1/2022 | Filing → |
Rubius Therapeutics, Inc. RUBY | Award | 125,000 | $0.00 | $0 | 125,000 | 1/31/2022 Filed: 2/1/2022 | Filing → |
Rubius Therapeutics, Inc. RUBY | Award | 50,000 | $0.00 | $0 | 50,000 | 8/31/2021 Filed: 9/1/2021 | Filing → |
Rubius Therapeutics, Inc. RUBY | Award | 150,000 | $0.00 | $0 | 150,000 | 8/31/2021 Filed: 9/1/2021 | Filing → |
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
60,000
Price
-
Value
-
Type
Purchase
Shares
7,363
Price
$1.79
Value
$13K
Type
Purchase
Shares
637
Price
$1.82
Value
$1K
Type
Purchase
Shares
12,000
Price
$1.50
Value
$18K
Type
Award
Shares
25,000
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Sale
Shares
10,385
Price
$0.13
Value
$1K
Rubius Therapeutics, Inc.
RUBY
Type
Sale
Shares
3,878
Price
$0.25
Value
$970
Rubius Therapeutics, Inc.
RUBY
Type
Exercise
Shares
7,500
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Exercise
Shares
7,500
Price
-
Value
-
Rubius Therapeutics, Inc.
RUBY
Type
Sale
Shares
5,737
Price
$0.80
Value
$5K
Rubius Therapeutics, Inc.
RUBY
Type
Exercise
Shares
12,500
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Exercise
Shares
12,500
Price
-
Value
-
Type
Award
Shares
38,400
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Award
Shares
30,000
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Award
Shares
125,000
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Award
Shares
50,000
Price
$0.00
Value
$0
Rubius Therapeutics, Inc.
RUBY
Type
Award
Shares
150,000
Price
$0.00
Value
$0
AI Agent
Try asking...